July 30, 2014 6:07 PM ET

Biotechnology

Company Overview of Chlorion Pharma, Inc.

Company Overview

Chlorion Pharma, Inc., a biopharmaceutical company, develops therapeutics for the treatment of neuropathic pain and epilepsy. It offers CLP635, a molecule for the treatment of neuropathic pain and partial seizures. The company was founded in 2004 and is based in Laval, Canada.

500 Cartier Boulevard West

Suite 132

Laval, QC H7V 2B7

Canada

Founded in 2004

Phone:

450-781-1552

Fax:

450-781-1560

Key Executives for Chlorion Pharma, Inc.

Co-Founder
Co-Founder and Member of Scientific Advisory Board
Chief Development Officer
Senior Director of Chemistry & Pharmaceutical Development
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
MDS Associés Neuroscience Inc. Americas
7662114 Canada Inc. Americas
SensorChem International Corporation Americas
Viropro Canada Inc. Americas
Capital 21 Holdings Inc. Americas

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Chlorion Pharma, Inc., please visit www.chlorion.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.